Beijing FortuneStar S&T Development

Beijing FortuneStar S&T Development Co., Ltd. is a medical technology company based in Beijing, China, specializing in the development and manufacture of in vitro diagnostic (IVD) products. The company's core business revolves around point-of-care testing (POCT) solutions, particularly blood glucose monitoring systems for diabetes management. In addition to glucose meters, FortuneStar produces diagnostic tools for monitoring uric acid and hemoglobin levels, catering to patients with metabolic and hematologic conditions. The company operates a manufacturing facility that adheres to international quality standards, including ISO and CE certifications, allowing it to export products globally. FortuneStar also expanded its portfolio to include rapid diagnostic kits for infectious diseases, such as COVID-19 antigen tests, to meet public health demands. Their products are designed for both professional clinical use and home-based patient monitoring, emphasizing accuracy and ease of use.